2024
5. Lower SV2A Synaptic Density Following Chronic Stress and Relationships With Cognitive Impairment: An In Vivo [18F]SynVesT-1 and PET Study in Male and Female Rats
Asch R, Cai Z, DiLeone R, Carson R, Liston C, Esterlis I. 5. Lower SV2A Synaptic Density Following Chronic Stress and Relationships With Cognitive Impairment: An In Vivo [18F]SynVesT-1 and PET Study in Male and Female Rats. Biological Psychiatry 2024, 95: s75-s76. DOI: 10.1016/j.biopsych.2024.02.183.Peer-Reviewed Original Research
2020
PET Imaging of Synaptic Vesicle Protein 2A
Finnema S, Li S, Cai Z, Naganawa M, Chen M, Matuskey D, Nabulsi N, Esterlis I, Holmes S, Radhakrishnan R, Toyonaga T, Huang Y, Carson R. PET Imaging of Synaptic Vesicle Protein 2A. 2020, 993-1019. DOI: 10.1007/978-3-030-53176-8_29.ChaptersSynaptic vesicle protein 2APositron emission tomographyAntiepileptic drug levetiracetamInitial PET studiesPET imagingPET studiesSynaptic densityDrug levetiracetamHigh-affinity SV2A ligandsBrain regionsSynaptic density lossNeuropathological diseasesDisease-modifying therapiesLarge patient cohortMajor depressive disorderProtein 2APET imaging resultsPosttraumatic stress disorderPatient groupPatient cohortDepressive disorderClinical valueParkinson's diseaseEfficacy assessmentSynaptic vesicle proteins